Dr. Pal leads Orlando-based Interventional Cardiology & Vascular Consultants, according to a Sept. 15 Justice Department news release.
Four things to know:
- The monetary settlement resolves accusations that Dr. Pal submitted false claims to the federal healthcare programs for unnecessary ablations and vein stent procedures from Jan. 1, 2013, to Dec. 31, 2019.
- The allegations against Dr. Pal said he falsified EHR records by exaggerating or faking patient symptoms to justify the procedures.
- The vein ablations were allegedly performed exclusively or primarily by one or more ultrasound technicians, which is outside the scope of their practice.
- Dr. Pal and Orlando and Interventional Cardiology & Vascular Consultants entered a multiyear integrity agreement with HHS and the Office of Inspector General to ensure the alleged incidents do not reoccur. The agreement contains training and reporting requirements, quarterly claim reviews by an independent organization, possible exclusions from Medicare and Medicaid, and stipulated penalties.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
